Trading a LQDA straddle lets you take a pure volatility position on Liquidia Corp without committing to a direction. Liquidia Corp's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate LQDA straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on LQDA profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Liquidia Corp stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the LQDA straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the LQDA straddle is the cleanest expression of that view. Our scanner prices every LQDA straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a LQDA straddle into a catalyst or short a LQDA straddle to harvest decay, the options straddle setups that matter are all in one place.
